Rx share by drug type in select public drug plans Canada 2020/2021

Prescriptions of patented drugs made up nine percent of all prescriptions under public drug plans in Canada in fiscal year 2020/2021. This statistic depicts the share of prescriptions by drug type in select public drug plans in Canada from FY 2014/15 to FY 2020/21.

Share of prescriptions by drug type in select public drug plans in Canada from 2014/2015 to 2020/2021

Characteristic	Patented	Multi-source non-patented	Multi-source non-patented and other*	Single-source non-patented	Other**
2014/15	12.5%	-	86.3%	1.2%	-
2015/16	11.5%	83%	-	1.9%	3.7%
2016/17	10.8%	83.6%	-	1.9%	3.8%
2017/18	11.1%	83.4%	-	2%	3.5%
2018/19	9.8%	84.4%	-	4.1%	1.7%
2019/20	9%	86.5%	-	2.9%	1.6%
2020/21	9%	87.4%	-	2.5%	1.2%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

2023

More information

Region

Canada

Survey time period

fiscal years 2014/2015 to 2020/2021

Supplementary notes

Including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, Yukon, and the Non-Insured Health Benefits Program.
* Due to data availability issues, “multi-source non-patented” and “other” were combined for 2014/15.
** This market segment includes devices, compounded drugs, and other products that are reimbursed by public drug plans but do not have a Health Canada assigned Drug Identification Number (DIN).

Citation formats